Hurdles of publication: to authors to overcome

Summary The experience of work in BioImpacts and direct involvement in whole the process of publication inspired us to tackle here the dimensions which we recognize as problematic areas in publication, namely, scientific setbacks, language and technical issues. Authors besides readers as competent future authors are urged not to neglect the significance of well-writing either through considering the language-associated issues or attending the technical matters besides enriching the scientific content. The article offers a scope for the authors to manifest themselves, hence we suggest how to best appear in this play

How to Select a Journal to Submit and Publish Your Biomedical Paper?

Introduction: selection of journal for publication purpose is one of concerns of biomedical researchers. They apply various criteria to choose appropriate journal. Here, we have tried to collect main criteria biomedical researchers use to select a journal to submit their work. Methods: we collected these criteria through focus group conversations with researchers during our careers, feedbacks from participants of our scientific writing workshops and non-systematic reviewing of some related literature. Results: we have presented a summative and informative guidance in selection of biomedical journals for biomedical paper submission and publication. Conclusion: Categorized criteria as a mnemonic tool for authors may help the authors in journal selection process

The conundrum of dietary antioxidants in cancer chemotherapy

International audienceAbstract Although chemotherapy succeeds in reducing tumor burden, the efficacy is limited due to acquired drug resistance and often irreparable side effects. Studies show that antioxidants may influence the response to chemotherapy and its side effects, although their use remains controversial. The evidence shows that some chemo-drugs induce oxidative stress and lead to normal tissue apoptosis and the entry of cancer cells to a dormant G0 state. Through the suppression of oxidative stress, antioxidants could protect normal cells and bring the tumor out of dormancy so as to expose it to chemotherapies. This review is focused on the redox biology of cancer/normal cells and association of reactive oxygen species with drug resistance, cancer dormancy, and side effects. To this end, evidence from cellular, animal, and clinical studies is provided to better understand the conundrum of dietary antioxidants in cancer chemotherapy